MELD exceptions and rates of waiting list outcomes

American Journal of Transplantation

Volumn 11, Issue 11, 2011, Pages 2362-2371

  Massie, A B ^a,b   Caffo, B ^b   Gentry, S E ^c   Hall, E C ^a   Axelrod, D A ^d   Lentine, K L ^e   Schnitzler, M A ^e   Gheorghian, A ^e   Salvalaggio, P R ^f   Segev, D L ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNITED STATES NAVAL ACADEMY   (United States)

^d DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^e SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

Liver transplantation; MELD score; Organ allocation

Indexed keywords

ADULT; ARTICLE; COMPARATIVE STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MODEL; MODEL FOR END STAGE LIVER DISEASE SCORING SYSTEM; MORTALITY; ORGAN DONOR; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCORING SYSTEM;

CARCINOMA, HEPATOCELLULAR; END STAGE LIVER DISEASE; FEMALE; HEALTH CARE RATIONING; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; TISSUE AND ORGAN PROCUREMENT; WAITING LISTS;

EID: 84855417506     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03735.x     Document Type: Article

References (20)

1. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patientswith end-stage liver disease. Hepatology 2001; 33: 464-470. (Pubitemid 32119037)
2. Voigt MD, Zimmerman B, Katz DA, Rayhill SC. New national liver transplant allocation policy: Is the regional review board process fair? Liver Transplant 2004; 10: 666-674. (Pubitemid 38628228)
3. Freeman RB, Jr., Gish RG, Harper A, et al.Model for end-stage liver disease (MELD) exception guidelines: Results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula. Liver Transplant 2006; 12(Suppl 3): S128-S136. (Pubitemid 44911794)
4. Rodriguez-Luna H, Vargas HE, Moss A, Reddy KS, Freeman RB, Mulligan D. Regional variations in peer reviewed liver allocation under the MELD system. Am J Transplant 2005 5: 2244-2247. (Pubitemid 41648472)
5. Wiesner R, Lake JR, Freeman RB, Gish RG. Model for end-stage liver disease (MELD) exception guidelines. Liver Transplant 2006; 12(Suppl 3): S85-S87. (Pubitemid 44911776)
6. Sulieman BM, Hunsicker LG, Katz DA, Voigt MD. OPTN policy regarding prioritization of patientswith hepatopulmonary syndrome: Does it provide equitable organ allocation? Am J Transplant 2008; 8: 954-964. (Pubitemid 351537751)
7. Thuluvath PJ, Guidinger MK, Fung JJ, Johnson LB, Rayhill SC, Pelletier SJ. Liver transplantation in the United States, 1999-2008. Am J Transplant 10(Pt 2): 1003-1019.
8. Washburn K. Model for end-stage liver disease and hepatocellular carcinoma: A moving target. Transplant Rev 24: 11-17.
9. Freeman RB, Jr., Wiesner RH, Roberts JP, McDiarmid S, Dykstra DM, Merion RM. Improving liver allocation: MELD and PELD. Am J Transplant 2004; 4(Suppl 9): 114-131. (Pubitemid 38859000)
10. Washburn K, Edwards E, Harper A, Freeman R. Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system. Am J Transplant 10: 1643-1648.
11. Roayaie K, Feng S. Allocation policy for hepatocellular carcinoma in the MELD era: Room for improvement? Liver Transplant 2007; 13(Suppl 2): S36-S43. (Pubitemid 350168172)
12. Agresti A. Categorical data analysis. New York:Wiley-Interscience 2002.
13. Louis TA, Zeger SL. Effective communication of standard errors and confidence intervals. Biostatistics 2009; 10: 1-2. (Pubitemid 352847901)
14. Massie AB, Desai NM, Montgomery RA, Singer AL, Segev DL. Improving distribution efficiency of hard-to-place deceased donor kidneys: Predicting probability of discard or delay. Am J Transplant 2010; 10: 1613-1620.
15. Massie AB, Stewart DE, Dagher NN, Montgomery RA, Desai NM, Segev DL. Center-level patterns of indicated willingness to and actual acceptance of marginal kidneys. Am J Transplant 2010; 10: 2472-2480.
16. Massie AB, Zeger SL, Montgomery RA, Segev DL. The effects of DonorNet 2007 on kidney distribution equity and efficiency. Am J Transplant 2009; 9: 1550-1557.
17. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: Competing risks and multi-state models. Stat Med 2007; 26: 2389-2430. (Pubitemid 46730255)
18. Krowka MJ, Fallon MB. Liver transplantation for hepatopulmonary syndrome (HPS): What is the MESSAGE? Am J Transplant 2008; 8: 911-912. (Pubitemid 351537765)
19. Fallon MB, Mulligan DC, Gish RG, Krowka MJ. Model for endstage liver disease (MELD) exception for hepatopulmonary syndrome. Liver Transplant 2006; 12(Suppl 3): S105-S107. (Pubitemid 44911784)
20. Salvalaggio PR, Neighbors K, Kelly S, et al. Regional variation and use of exception letters for cadaveric liver allocation in children with chronic liver disease. Am J Transplant 2005; 5: 1868-1874. (Pubitemid 41039859)